16.04.24 | Vollzeit | Unterschleißheim | Aenova GroupOf cost, time, functionality, safety and according to client expectations Creating and scheduling of project plans that will meet the project’s objectives through the Engineering, Design, Construction, Commissioning and Qualification phases Define scope of work and deliverables together with the relevant
Später ansehen16.04.24 | Vollzeit | Unterschleißheim | Aenova GroupOf cost, time, functionality, safety and according to client expectations Creating and scheduling of project plans that will meet the project’s objectives through the Engineering, Design, Construction, Commissioning and Qualification phases Define scope of work and deliverables together with the relevant
Später ansehen16.04.24 | Vollzeit | Unterschleißheim | Aenova GroupOf cost, time, functionality, safety and according to client expectations Creating and scheduling of project plans that will meet the project’s objectives through the Engineering, Design, Construction, Commissioning and Qualification phases Define scope of work and deliverables together with the relevant
Später ansehen08.04.24 | Vollzeit | Unterschleißheim | CatalYm GmbHCatalYm GmbH is a well-funded, clinical-stage biotechnology company focused on revolutionizing cancer treatment through the development of Visugromab, an innovative immunotherapy designed for patients with advanced solid tumors. Visugromab targets the immunosuppressive cytokine GDF-15, which
Später ansehen08.04.24 | Vollzeit | Unterschleißheim | CatalYm GmbHCatalYm GmbH is a well-funded, clinical-stage biotechnology company focused on revolutionizing cancer treatment through the development of Visugromab, an innovative immunotherapy designed for patients with advanced solid tumors. Visugromab targets the immunosuppressive cytokine GDF-15, which
Später ansehen08.04.24 | Vollzeit | Unterschleißheim | CatalYm GmbHCatalYm GmbH is a well-funded, clinical-stage biotechnology company focused on revolutionizing cancer treatment through the development of Visugromab, an innovative immunotherapy designed for patients with advanced solid tumors. Visugromab targets the immunosuppressive cytokine GDF-15, which
Später ansehen08.04.24 | Vollzeit | Unterschleißheim | CatalYm GmbHCatalYm GmbH is a well-funded, clinical-stage biotechnology company focused on revolutionizing cancer treatment through the development of Visugromab, an innovative immunotherapy designed for patients with advanced solid tumors. Visugromab targets the immunosuppressive cytokine GDF-15, which
Später ansehen08.04.24 | Vollzeit | Unterschleißheim | CatalYm GmbHCatalYm GmbH is a well-funded, clinical-stage biotechnology company focused on revolutionizing cancer treatment through the development of Visugromab, an innovative immunotherapy designed for patients with advanced solid tumors. Visugromab targets the immunosuppressive cytokine GDF-15, which
Später ansehen08.04.24 | Vollzeit | Unterschleißheim | CatalYm GmbHCatalYm GmbH is a well-funded, clinical-stage biotechnology company focused on revolutionizing cancer treatment through the development of Visugromab, an innovative immunotherapy designed for patients with advanced solid tumors. Visugromab targets the immunosuppressive cytokine GDF-15, which
Später ansehenVerpassen Sie nie wieder einen passenden Job!
Alle Jobs für Design in Unterschleißheim kostenlos abonnieren.